Kare Schultz - President and CEO, Director at Teva Pharmaceutical Industries Ltd

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kare Schultz since 7/7/2023

Holdings reported by Kare Schultz for Teva Pharmaceutical Industries Ltd

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Ordinary Shares 1,542,471 $15 M $9.73 Nov 1, 2022 Direct
Restricted Share Units 0 Nov 1, 2022 Direct Ordinary Shares

Transactions reported by Kare Schultz for Teva Pharmaceutical Industries Ltd

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership